Cargando…

The association between serum magnesium levels and community-acquired pneumonia 30-day mortality

BACKGROUND: Community acquired pneumonia (CAP) is a common illness affecting hundreds of millions worldwide. Few studies have investigated the relationship between serum magnesium levels and outcomes of these patients. We aimed to study the association between serum magnesium levels and 30-day morta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nasser, Roni, Naffaa, Mohammad E., Mashiach, Tanya, Azzam, Zaher S., Braun, Eyal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307202/ https://www.ncbi.nlm.nih.gov/pubmed/30587164 http://dx.doi.org/10.1186/s12879-018-3627-2

Ejemplares similares

Serum inorganic phosphorus levels predict 30-day mortality in patients with community acquired pneumonia
por: Naffaa, Mohammad E., et al.
Publicado: (2015)

Is elevated Red cell distribution width a prognostic predictor in adult patients with community acquired Pneumonia?
por: Braun, Eyal, et al.
Publicado: (2014)

Elevated red cell distribution width predicts poor outcome in young patients with community acquired pneumonia
por: Braun, Eyal, et al.
Publicado: (2011)

The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia
por: Mortensen, Eric M, et al.
Publicado: (2005)

Predictors of 30-day readmission following hospitalisation with community-acquired pneumonia
por: Chakrabarti, Biswajit, et al.
Publicado: (2021)

The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia
por: Mortensen, Eric M, et al.
Publicado: (2005)

Incidence of Avoidable 30-Day Readmissions Following Hospitalization for Community-Acquired Pneumonia in France
por: Boussat, Bastien, et al.
Publicado: (2022)

Performance and comparison of assessment models to predict 30-day mortality in patients with hospital-acquired pneumonia
por: Wen, Jia-Ning, et al.
Publicado: (2020)

Using Data-Driven Rules to Predict Mortality in Severe Community Acquired Pneumonia
por: Wu, Chuang, et al.
Publicado: (2014)

Ability of the LACE index to predict 30-day hospital readmissions in patients with community-acquired pneumonia
por: Dobler, Claudia C., et al.
Publicado: (2020)

Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital
por: Akagi, Takanori, et al.
Publicado: (2019)

Impact of frailty on 30-day and 1-year mortality in hospitalised elderly patients with community-acquired pneumonia: a prospective observational study
por: Luo, Jia, et al.
Publicado: (2020)

High-Normal Serum Magnesium and Hypermagnesemia Are Associated With Increased 30-Day In-Hospital Mortality: A Retrospective Cohort Study
por: Tan, Liao, et al.
Publicado: (2021)

The prevalence of anemia and its association with 90-day mortality in hospitalized community-acquired pneumonia
por: Reade, Michael C, et al.
Publicado: (2010)

Association of the Tyrosine/Nitrotyrosine pathway with death or ICU admission within 30 days for patients with community acquired pneumonia
por: Baumgartner, Thomas, et al.
Publicado: (2018)

Antibiotic prescription consistent with guidelines in emergency department is associated with 30-day survival in severe community-acquired pneumonia
por: Kang, Seung Hyun, et al.
Publicado: (2021)

4221 Lower Serum TWEAK Concentration is a Biomarker for Mortality in Community Acquired Pneumonia
por: Parra, Daniela, et al.
Publicado: (2020)

Blood urea nitrogen variation upon admission and at discharge in patients with heart failure
por: Khoury, Johad, et al.
Publicado: (2019)

Factors affecting 90-day mortality in community and hospital acquired pneumonia patients with or without acute kidney injury
por: Hoşgün, Derya, et al.
Publicado: (2022)

Serum levels of immunoglobulins and severity of community-acquired pneumonia
por: de la Torre, Mari C, et al.
Publicado: (2016)

Effect of corticosteroids on mortality in patients with community-acquired pneumonia
por: Chen, Shangzhong, et al.
Publicado: (2023)

Plasma lipid profiling for the prognosis of 90-day mortality, in-hospital mortality, ICU admission, and severity in bacterial community-acquired pneumonia (CAP)
por: Banoei, Mohammad M., et al.
Publicado: (2020)

Adherence to Institutional Guidelines for Community and Nosocomial Pneumonia and Its Impact on In-hospital Mortality and 30-day Readmission in a Community Health System
por: Lanza, David, et al.
Publicado: (2017)

Development and Validation of a Nomogram for Predicting 28-Day Mortality on Admission in Elderly Patients with Severe Community-Acquired Pneumonia
por: Song, Yansha, et al.
Publicado: (2022)

805 Predictors of 30-day hospital readmission in patients with community-onset pneumonia
por: Gross, Alan E., et al.
Publicado: (2014)

Blood urea nitrogen to serum albumin ratio independently predicts mortality and severity of community-acquired pneumonia
por: Ugajin, Motoi, et al.
Publicado: (2012)

An Administrative Claims Model for Profiling Hospital 30-Day Mortality Rates for Pneumonia Patients
por: Bratzler, Dale W., et al.
Publicado: (2011)

Do fluoroquinolones actually increase mortality in community-acquired pneumonia?
por: Agarwal, Ritesh
Publicado: (2006)

Severe community-acquired pneumonia: risk factors for in-hospital mortality
por: Pereira, JM, et al.
Publicado: (2012)

Changing Bacteriological Profile and Mortality Trends in Community Acquired Pneumonia
por: Khadanga, Sagar, et al.
Publicado: (2014)

Impact of microbial Aetiology on mortality in severe community-acquired pneumonia
por: Quah, Jessica, et al.
Publicado: (2018)

Population-based incidence and mortality of community-acquired pneumonia in Germany
por: Theilacker, Christian, et al.
Publicado: (2021)

Bacterial etiology and mortality rate in community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia in Thai university hospital
por: Poovieng, Jaturon, et al.
Publicado: (2022)

COMMUNITY-ACQUIRED PNEUMONIA
por: Haas, Andrew R., et al.
Publicado: (2009)

Community-acquired pneumonia
por: File, Thomas M
Publicado: (2003)

Community-Acquired Pneumonia
por: Sialer, Salvador, et al.
Publicado: (2014)

Community Acquired Pneumonia
por: Wunderink, Richard G., et al.
Publicado: (2016)

Community-Acquired Pneumonia
por: Boza Costagliola, María Lina
Publicado: (2020)

Community Acquired Pneumonia
por: Wunderink, Richard G.
Publicado: (2019)

Community-Acquired Pneumonia
por: Rider, Ashley C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_akj2slb69n03lglueglgb0vbrb